Allegro's DME Drug Could Over-Throw Off-Label Avastin, Says CMO

Phase IIb data prove Allegro Ophthalmics' injectable diabetic macular edema treatment, Luminate, is non-inferior to marketed VEGF treatments, but the drug still faces entry into a competitive market with numerous approved options and rivalry from cheaper alternatives used off-label for DME patients.